Get started
Author

Junjie Li

Challenges to effective cancer control in China, India, and Russia
2014 · Paul E Goss, Kathrin Strasser-Weippl, et al. · The Lancet Oncology · 496
Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial
2022 · Li Chen, Yi-Zhou Jiang, et al. · Clinical Cancer Research · 106
PDF
Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial
2020 · Junjie Li, Keda Yu, et al. · Journal of Clinical Oncology · 104
Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial
2024 · Lei Fan, Zhong-Hua Wang, et al. · The Lancet Oncology · 72
Expression of Concern: TIEG1 induces apoptosis through mitochondrial apoptotic pathway and promotes apoptosis induced by homoharringtonine and velcade
2007 · Wei Jin, Genhong Di, et al. · FEBS Letters · 42
PDF
Development of High-Resolution Dedicated PET-Based Radiomics Machine Learning Model to Predict Axillary Lymph Node Status in Early-Stage Breast Cancer
2022 · Jingyi Cheng, Caiyue Ren, et al. · Cancers · 41
PDF
Fulvestrant in the treatment of hormone receptor‐positive/human epidermal growth factor receptor 2‐negative advanced breast cancer: A review
2019 · Junjie Li, Zhonghua Wang, et al. · Cancer Medicine · 32
PDF
Pregnancy-associated breast cancer in women from Shanghai: risk and prognosis
2014 · Kathrin Strasser-Weippl, Ritesh Ramchandani, et al. · Breast Cancer Research and Treatment · 29
Clinical feasibility and oncological safety of non-radioactive targeted axillary dissection after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: a prospective diagnostic and prognostic study
2023 · Si-Yu Wu, Jian-Wei Li, et al. · International Journal of Surgery · 27
Feasibility of sentinel lymph node biopsy omission after integration of 18F-FDG dedicated lymph node PET in early breast cancer: a prospective phase II trial
2022 · Junjie Li, Jingyi Cheng, et al. · Cancer Biology and Medicine · 21
PDF
Adjuvant chemotherapy increases the prevalence of fat necrosis in immediate free abdominal flap breast reconstruction
2014 · Lin Li, Ying Chen, et al. · Journal of Plastic Reconstructive & Aesthetic Surgery · 21
MicroRNA-199a-3p is downregulated in gastric carcinomas and modulates cell proliferation
2013 · W. Peng, Z.-Y. Chen, et al. · Genetics and Molecular Research · 20
PDF
Metastatic breast cancer patients with lung or liver metastases should be distinguished before being treated with fulvestrant
2019 · Min He, Jun‐Jie Li, et al. · Cancer Medicine · 19
PDF
Neoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II study
2024 · Min He, Shuang Hao, et al. · EClinicalMedicine · 16
The comparison of efficacy and safety evaluation of vacuum-assisted Elite 10-G system and the traditional BARD 14-G core needle in breast diagnosis: an open-label, parallel, randomized controlled trial
2023 · Ying Zhang, Junjie Li, et al. · International Journal of Surgery · 14
Spatiotemporal Patterns of Loco-Regional Recurrence After Breast-Conserving Surgery
2021 · Fei-Lin Qu, Rui Mao, et al. · Frontiers in Oncology · 13
Combination of famitinib with camrelizumab plus nab-paclitaxel as first-line treatment for patients with immunomodulatory advanced triple-negative breast cancer (FUTURE-C-PLUS): A prospective, single-arm, phase 2 study.
2021 · Li Chen, Shao Zhimin, et al. · Journal of Clinical Oncology · 12
A retrospective analysis of serum tumor markers found in non-small cell lung cancer
2016 · Pijun Yu, Qin Hu, et al. · Journal of Cancer Research and Therapeutics · 12
A prospective, phase II, neoadjuvant study based on chemotherapy sensitivity in HR+/HER2‐ breast cancer‐FINEST study
2025 · Li Chen, Wen‐Ya Wu, et al. · 癌症：英文版 · 11
PDF
Rational and trial design of FASCINATE-N: a prospective, randomized, precision-based umbrella trial
2024 · Wen-Jia Zuo, Li Chen, et al. · Therapeutic Advances in Medical Oncology · 11
Efficacy and Safety of Neoadjuvant TQB2102 in Locally Advanced or Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: A Randomized, Open-Label, Multicenter, Phase II Trial
2025 · Jun-Jie Li, Wen-Juan Zhang, et al. · Journal of Clinical Oncology · 10
Platinum is essential in neoadjuvant treatment of triple-negative breast cancer: a network meta-analysis
2022 · Junjie Li, Li Chen, et al. · Cancer Biology and Medicine · 10
PDF
Omission of axillary surgery for ipsilateral breast tumor recurrence with negative nodes after previous breast-conserving surgery: is it oncologically safe?
2022 · Fei-Lin Qu, Cai-Jin Lin, et al. · Breast Cancer Research and Treatment · 5
PDF
Breast Cancer-Specific Mortality Pattern and Its Changing Feature According to Estrogen Receptor Status in Two Time Periods
2016 · Junjie Li, Yirong Liu, et al. · PLoS ONE · 5
PDF
Synergistic inhibition of TNBC by USP33 and TAP63 through autophagy and ferroptosis activation
2025 · Feilin Qu, Wei Jian, et al. · Cellular and Molecular Life Sciences · 4
PDF
Works count: 49
Citation count: 1,176
H-index: 14
I10-index: 22
Year
Topic
Type